2012 Satellite Symposia

Satellite Symposia at the ESMO 14th World Congress on Gastrointestinal Cancer
All symposia will take place on Level 1

Thursday, 28 June 2012
13:00 - 14:30

New treatment paradigms in the management of mCRC

Supported by: F. Hoffmann-La Roche Ltd
Room 111-112
View PDF Agenda

Chemoradiation with SIR-Spheres microspheres – a new reality in colorectal liver metastases (CLM)

Supported by: Sirtex Medical Europe GmbH
Room 113-115
View PDF Agenda

Working Towards Improving Outcomes in GI Malignancies with Targeted Therapeutic Strategies

Supported by: Novartis Oncology
Room 116-117
View PDF Agenda

Pancreatic Ductal Adenocarcinoma: Can New Targets and New Drugs Finally Change the Playing Field?

Supported by: Celgene Corporation
Room 116-117
View PDF Agenda

Friday, 29 June 2012
13:15 - 14:45

Personalized treatment – A New Standard for Prolonging Overall Survival in mCRC

Supported by: Merck Serono
Room 111-112
View PDF Agenda

Regional Best Practices in Staging & Management of Hepatocellular Carcinoma

Supported by: Lilly Oncology
Room 113-115
View PDF Agenda

The need for a new fluoropyrimidine in advanced gastric cancer treatment

Supported by: Nordic Pharma
Room 116-117
View PDF Agenda

Saturday, 30 June 2012
13:00 - 14:30

THE 8TH ESO COLORECTAL CANCER OBSERVATORY: Innovation and care in the next 12 months

Supported by: European School of Oncology
Room 111-112
View PDF Agenda

Illuminating New Possibilities: Assessing Unmet Needs in Metastatic Colorectal Cancer (mCRC)

Supported by: Bayer Healthcare
Room 113-115
View PDF Agenda

Sharpening the Focus: Enhancing Clinical Outcomes in Metastatic Colorectal Cancer

Supported by: Sanofi Oncology and Regeneron
Room 116-117
View PDF Agenda